MarcoM.MulaMarcoM., Brivaracetam for the treatment of epilepsy in adults, „Expert Review of Neurotherapeutics”, 14 (4), 2014, s. 361–365, DOI: 10.1586/14737175.2014.896200, PMID: 24625006.
Nathalie T.N.T.SanonNathalie T.N.T., JonathanJ.GagnéJonathanJ., Daniele C.D.C.WolfDaniele C.D.C., SoumiaS.AboulamerSoumiaS., Ciprian M.C.M.BosoiCiprian M.C.M., Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model, „Epilepsy & Behavior”, 79, 2018, s. 117–125, DOI: 10.1016/j.yebeh.2017.11.019, PMID: 29287214.
MarcoM.MulaMarcoM., Brivaracetam for the treatment of epilepsy in adults, „Expert Review of Neurotherapeutics”, 14 (4), 2014, s. 361–365, DOI: 10.1586/14737175.2014.896200, PMID: 24625006.
Nathalie T.N.T.SanonNathalie T.N.T., JonathanJ.GagnéJonathanJ., Daniele C.D.C.WolfDaniele C.D.C., SoumiaS.AboulamerSoumiaS., Ciprian M.C.M.BosoiCiprian M.C.M., Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model, „Epilepsy & Behavior”, 79, 2018, s. 117–125, DOI: 10.1016/j.yebeh.2017.11.019, PMID: 29287214.